AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Ambulatory Continuous Monitoring Using Remote Monitoring Medicine Within Patient's Care Pathway Following Colorectal Surgery (CONTACT-GRECCAR 21)

RecruitingNAAges 18 Years - anyAllNantes University Hospital
💬

In plain words

What the trial is, and whether it could suit you

The goal of this Clinical Investigation is to evaluate the effectiveness of implementing the discharge protocol of the remote monitoring platform after colorectal surgery in patients at risk of hospital readmission. Participants will be randomized into either the "30 days of remote monitoring" group or the "conventional discharge" group. The patient returns to the site for their postoperative visit at 30 days and is contacted by phone 90 days after their surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria : * Man or woman over 18 years old at the time of the J0 visit, * Patient who underwent surgery less than 28 days ago, or who is scheduled to undergo colorectal surgery not managed as an outpatient procedure at the investigational center, including resection of at least one colonic or rectal segment and/or an anastomosis involving the colon or rectum, * At least one of the following two criteria: * Anticipated early discharge (within 24 hours following laparoscopic surgery without stoma and without diversion, and within 5 days following laparotomy and/or surgery with stoma and/or rectal surgery) for a procedure that is not usually managed as an outpatient surgery in routine practice, * Estimated risk of hospital readmission greater than 10% according to the nomogram of Tevis et al. \[15\], adapted to the postoperative context in digestive surgery (\>120 points according to this score). * Patient affiliated with a health insurance plan, * Patient who has signed the study consent form. Exclusion Criteria: * Discharge to a rehabilitation center requested by the patient, * Condition managed on an outpatient basis in routine practice for this type of patient, * Patient eligible for home hospitalization services, * Suicidal or hetero-aggressive risk in a patient living alone at home * Homeless patient, * Pregnant or breastfeeding women, * Patient under legal guardianship, curatorship, or protected legal status, * Patient already enrolled in an interventional postoperative follow-up study.
💊

What it tests

  • Remote monitoring platform
📍

Where

14 sites
CHU Angers
Angers, France
Clinique Tivoli- Ducos
Bordeaux, France
CHU Grenoble
Grenoble, France
Centre Hospitalier Lyon-Sud
Lyon, France
CHU Timone - Assistance publique-Hôpitaux de Marseille
Marseille, France
Hôpital Nord - Assistance publique- Hôpitaux de Marseille
Marseille, France
Institut Paoli Calmettes
Marseille, France
CHU Nantes
Nantes, France

…and 6 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy